Elucidating asthma phenotypes and endotypes: progress towards personalized medicine
Annals of Allergy, Asthma & Immunology
May 2016 Volume 116, Issue 5, Pages 394-401
Participants will be able to demonstrate increased knowledge of the clinical treatment of allergy/asthma/immunology and how new information can be applied to their own practices.
Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Committee Members:
Mauli Desai, MD (Author)
John Oppenheimer, MD (Author)
Jonathan A. Bernstein, MD (CME Subcommittee)
Guha Krishnaswamy, MD (CME Subcommittee)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)
Physicians involved in providing patient care in the field of allergy/asthma/immunology
At the conclusion of this activity, participants should be able to:
- Describe the heterogeneity of asthma
- Recognize new approaches to identifying asthma phenotypes and endotypes and how this may help tailor asthma therapy ons
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance